Thibaut Mussigmann , Benjamin Bardel , Jean-Pascal Lefaucheur
{"title":"期望使用θ波爆发刺激方案缓解疼痛。系统回顾","authors":"Thibaut Mussigmann , Benjamin Bardel , Jean-Pascal Lefaucheur","doi":"10.1016/j.clinph.2025.2110768","DOIUrl":null,"url":null,"abstract":"<div><div>Pain treatment by repetitive transcranial magnetic stimulation (rTMS) of the primary motor cortex (M1) is generally based on the conventional high-frequency (HF) paradigm. Newer theta-burst stimulation (TBS) paradigms are increasingly being used instead of HF-rTMS in various therapeutic applications, such as the treatment of depression. The literature was analyzed until January 2025 to appraise the analgesic effects of various TBS protocols (intermittent TBS, iTBS, continuous TBS, cTBS, and prolonged protocols, piTBS and pcTBS) in the context of experimental pain provoked in healthy subjects or chronic pain experienced by patients. In experimental pain (19 articles), analgesic effects were mainly produced by pcTBS of M1. Conversely, in chronic pain (19 articles), pain was rather relieved by iTBS of M1 used alone or for priming HF-rTMS. However, the data reported to date are too few to conclude on the interest of iTBS compared to HF-rTMS. Shorter iTBS sessions open up prospects for “accelerated” procedures, expected in the field of pain. However, it will be necessary to precisely control the stimulation parameters (e.g. the number of pulses delivered per session per day or the interval between sessions) and to evaluate their impact on cortical excitability and connectivity.</div></div>","PeriodicalId":10671,"journal":{"name":"Clinical Neurophysiology","volume":"176 ","pages":"Article 2110768"},"PeriodicalIF":3.7000,"publicationDate":"2025-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Expectations related to the use of theta burst stimulation protocols for pain relief. A systematic review\",\"authors\":\"Thibaut Mussigmann , Benjamin Bardel , Jean-Pascal Lefaucheur\",\"doi\":\"10.1016/j.clinph.2025.2110768\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Pain treatment by repetitive transcranial magnetic stimulation (rTMS) of the primary motor cortex (M1) is generally based on the conventional high-frequency (HF) paradigm. Newer theta-burst stimulation (TBS) paradigms are increasingly being used instead of HF-rTMS in various therapeutic applications, such as the treatment of depression. The literature was analyzed until January 2025 to appraise the analgesic effects of various TBS protocols (intermittent TBS, iTBS, continuous TBS, cTBS, and prolonged protocols, piTBS and pcTBS) in the context of experimental pain provoked in healthy subjects or chronic pain experienced by patients. In experimental pain (19 articles), analgesic effects were mainly produced by pcTBS of M1. Conversely, in chronic pain (19 articles), pain was rather relieved by iTBS of M1 used alone or for priming HF-rTMS. However, the data reported to date are too few to conclude on the interest of iTBS compared to HF-rTMS. Shorter iTBS sessions open up prospects for “accelerated” procedures, expected in the field of pain. However, it will be necessary to precisely control the stimulation parameters (e.g. the number of pulses delivered per session per day or the interval between sessions) and to evaluate their impact on cortical excitability and connectivity.</div></div>\",\"PeriodicalId\":10671,\"journal\":{\"name\":\"Clinical Neurophysiology\",\"volume\":\"176 \",\"pages\":\"Article 2110768\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2025-05-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Neurophysiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1388245725006200\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Neurophysiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1388245725006200","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
Expectations related to the use of theta burst stimulation protocols for pain relief. A systematic review
Pain treatment by repetitive transcranial magnetic stimulation (rTMS) of the primary motor cortex (M1) is generally based on the conventional high-frequency (HF) paradigm. Newer theta-burst stimulation (TBS) paradigms are increasingly being used instead of HF-rTMS in various therapeutic applications, such as the treatment of depression. The literature was analyzed until January 2025 to appraise the analgesic effects of various TBS protocols (intermittent TBS, iTBS, continuous TBS, cTBS, and prolonged protocols, piTBS and pcTBS) in the context of experimental pain provoked in healthy subjects or chronic pain experienced by patients. In experimental pain (19 articles), analgesic effects were mainly produced by pcTBS of M1. Conversely, in chronic pain (19 articles), pain was rather relieved by iTBS of M1 used alone or for priming HF-rTMS. However, the data reported to date are too few to conclude on the interest of iTBS compared to HF-rTMS. Shorter iTBS sessions open up prospects for “accelerated” procedures, expected in the field of pain. However, it will be necessary to precisely control the stimulation parameters (e.g. the number of pulses delivered per session per day or the interval between sessions) and to evaluate their impact on cortical excitability and connectivity.
期刊介绍:
As of January 1999, The journal Electroencephalography and Clinical Neurophysiology, and its two sections Electromyography and Motor Control and Evoked Potentials have amalgamated to become this journal - Clinical Neurophysiology.
Clinical Neurophysiology is the official journal of the International Federation of Clinical Neurophysiology, the Brazilian Society of Clinical Neurophysiology, the Czech Society of Clinical Neurophysiology, the Italian Clinical Neurophysiology Society and the International Society of Intraoperative Neurophysiology.The journal is dedicated to fostering research and disseminating information on all aspects of both normal and abnormal functioning of the nervous system. The key aim of the publication is to disseminate scholarly reports on the pathophysiology underlying diseases of the central and peripheral nervous system of human patients. Clinical trials that use neurophysiological measures to document change are encouraged, as are manuscripts reporting data on integrated neuroimaging of central nervous function including, but not limited to, functional MRI, MEG, EEG, PET and other neuroimaging modalities.